Pharmaceutical News and Articles

Biden Proposes That Insurers Cover Over-the-Counter Birth Control

Health insurers would be required to cover the cost of over-the-counter birth control and emergency contraception under new rules proposed by the White House on

Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety

Glaukos Corporation (NYSE GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal d

Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Healthy Preterm and Full-term Infants

RAHWAY, N.J., Oct. 17, 2024 Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced the presentation of positive results from th

Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48

Gilead Sciences, Inc. (Nasdaq GILD) and Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced new results from a Phase 2 clini

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

FDA Approves Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease

FDA Approves Vyloy (zolbetuximab-clzb) for the Treatment of Advanced Gastric and GEJ Cancer

Preventing, Treating Sports Injuries in Kids: A Guide

all the same qualities that helped them become good athletes. More informationThe American Academy of Pediatrics has more tips to prevent sports injuries in chi

Phase 2 study demonstrates the first successful clinical application of antifibrotic therapy for breast cancer

SAN DIEGO, Oct. 18, 2024. MeCo Diagnostics, a venture-backed startup dedicated to unlocking a new therapeutic modality for cancer, has announced a publication i

Want to Slowly Cut Down on Dietary Salt? Here's How

Did you know that sodium is the bad guy in salt, raising your risks for high blood pressure and other heart ills Luckily for Americans, the U.S. Food and Drug A